baber/WOPTO huggingface dataset:
Patent NZ-541641-A (NZ)
Title: Process for upgrading wood parts comprising a hydrothermolysis step using saturated steam
Inventor: BOONSTRA MICHIEL JAN
IPC: C08H8/00
Filed: 2004-01-29
Abstract: Process for upgrading wood parts, wherein the wood parts in a hydrothermolysis step are brought under the influence of saturated steam at a temperature in the range of 130-220 DEG C, such that a conversion of hemicellulose and lignin present in the wood parts takes place, wherein the wood parts are subsequently dried in a curing step to a moisture content which is lower than about 3 wt.% at a temperature in the range of 100-220 DEG C, characterized in that at least one dimension of each of the wood parts, at least before the hydrothermolysis step, is greater than about 10 cm, wherein the wood parts at the start of the hydrothermolysis step have an initial moisture content which is in the range of 10-25 wt.%.
Patent NZ-544484-A (NZ)
Title: Treatment of premature ejaculation
Inventor: VAISMAN JAKOV
IPC: A61K31/138
Filed: 2004-07-09
Abstract: Disclosed is a medicament for treating premature ejaculation comprising a combination of i) an antidepressant formulated for mucosal administration; or ii) an antidepressant formulated for administration to the Iungs; and iii) antidepressant formulated for local administration to at least part of the male genitalia; wherein each said antidepressant is independently selected from the group consisting of serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, norepinephrine dopamine reuptake inhibitors, serotonin antagonist and reuptake inhibitors, norepinephrine antagonist/serotonin antagonists, synthetically derived phenylpiperazine antidepressants, antagonists of the central L2-alpha2 auto and heteroadrenoceptors and mixtures thereof; and wherein the concentration of the antidepressant is between 1 to 10% by weight of said medicament.
Patent NZ-550577-A (NZ)
Title: An insulated lid for a pot which condences cooking steam on an upper plate then returns the water to the pot
Inventor: CIOETA DANIELA
IPC: A47J27/04
Filed: 2005-04-19
Abstract: A lid (1) for covering cooking containers (2) which condenses steam to liquid so that it may flow back into the cooking container (2) is disclosed. A plate for cooling vapour (3) is held outside and above the lid (1) by a support means (4). The lid has an upper (12) and lower (13) surface with an insulating barrier in-between. A plurality of channels (11) run through the lid, allowing the escape of vapour. The vapour on contacting the lower surface (31) of the plate (3), condenses and flows back inside the cooking container (2) through the plurality of channels (11) as liquid.
Patent NZ-555283-A (NZ)
Title: 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
Inventor: DELUCA HECTOR F
IPC: A61K31/59
Filed: 2005-11-18
Abstract: Provided is the compound 2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and related compounds which are useful to treat psoriasis, leukemia, cancer, multiple sclerosis and other diseases.
Patent NZ-560385-A (NZ)
Title: Glucuronidated nebivolol metabolites
Inventor: O'DONNELL JOHN P
IPC: A61K31/353
Filed: 2006-01-30
Abstract: Disclosed is a composition containing at least one diastereoisomers of nebivolol glucuronidated metabolite (as shown) which is Nebivolol-11-O-BETA-D-glucuronide where nebivolol is a mixture of d and l isomers of alpha,alpha'-[iminobismethylene]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol]. Also disclosed is the use of the composition in the preparation of a medicament for improving NO (nitrous oxide) release in a black patient; or treating cardiovascular disease especially congestive heart failure, hypertension, pulmonary hypertension, myocardial and cerebral infarctions, atherosclerosis, atherogenesis, thrombosis, ischemic heart disease, postangioplasty restenosis, coronary artery diseases, renal failure, stable, unstable and variant (Prinzmetal) angina, cardiac edema, renal insufficiency, nephrotic edema, hepatic edema, stroke, transient ischemic attacks, cerebrovascular accidents, restenosis, controlling blood pressure in hypertension, platelet adhesion, platelet aggregation, smooth muscle cell proliferation, pulmonary edema, vascular complications associated with the use of medical devices including stents, vascular wounds associated with the use of medical devices, pulmonary thromboembolism, cerebral thromboembolism, thrombophlebitis, thrombocytopenia and bleeding disorders.
Patent NZ-560551-A (NZ)
Title: Dosing regimes for trans-clomiphene
Inventor: PODOLSKI JOSEPH
IPC: A61K31/137
Filed: 2006-03-17
Abstract: Disclosed is a use of 0% to about 29% w/w of cis-clomiphene, and about 100% to about 71% trans-clomiphene or pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of male hypogonadism, lipodystrophy, benign prostate hypertrophy or prostate cancer, wherein the medicament is to be administered non-daily to a male patient and provides a dose of from about 5 to about 100 mg/trans-clomiphene.
Patent NZ-563934-A (NZ)
Title: Safety coatings
Inventor: WHITELEY REGINALD KEITH
IPC: C09D125/08
Filed: 2007-05-02
Abstract: Disclosed herein is an aqueous based composition for use as a floor coating comprising a combination of: a) an aqueous dispersion or emulsion comprising a base polymeric material and a surfactant, wherein the base polymeric material is selected from the group consisting of an acrylic, modified acrylic, urethane, styrene, alkylstyrene, stilibene polymer or copolymer, and mixtures thereof; and b) a crystalline polymeric material dissolved in a solvent, wherein the crystalline polymeric material is selected from the group consisting of acrylic polymers, methylate polymers, poly acrylic polymers, epoxy polymers, polycarbonate polymers, polyester polymers, polystyrene polymers, poly vinyl polymers, and polyurethanes or composites, derivatives or graft copolymers thereof; Wherein the crystalline polymeric material recrystallizes within the floor coating on drying so as to provide a rough textured surface in which crystals of the crystalline polymeric material are uniformly dispersed.
Patent NZ-569374-A (NZ)
Title: Refrigerator with side and top hand catch portions
Inventor: SASAKI AKIHIRO
Filed: 2008-06-25
Abstract: Disclosed is a refrigerator having a door with hand catch portions on side and on top of the door formed in a plate in a particular manner.
Patent NZ-575782-A (NZ)
Title: Movable demarcation element having observation unit and observation-based control capability
Inventor: VLAAR IWAN YVES
IPC: G05D1/00
Filed: 2007-10-02
Abstract: A system for demarcating an area, in particular for limiting the freedom of movement of free-roaming animals. The system is comprised of a movable demarcating element (2), a control system and observation means (100). The observation means (100) are designed to observe an entity near the movable demarcating element (2) and are operatively connected to the control system for transmitting a signal from the observation means (100) to the control system. The control system is designed to determine the magnitude and/or the moment of a next move of the movable demarcating element (2).
Patent NZ-578473-A (NZ)
Title: Aclinidium for use in respiratory disease
Inventor: BELETA SUPERVIA JORGE
IPC: A61K31/439
Filed: 2008-01-31
Abstract: Disclosed is the use of aclidinium, in the manufacture of a medicament for use in the treatment or prevention of a respiratory disease or condition in a patient by inhalation (such as acute or chronic bronchitis, emphysema, asthma and chronic obstructive pulmonary disease), without producing in said patient systemic antimuscarinic effects, wherein the patient is suffering from or susceptible to a condition which may be exacerbated by systemic antimuscarinic activity (such as schizophrenia, impaired concentration, confusion, agitation, delirium, attention deficit, impaired memory, respiratory depression, glaucoma, dry eye, increased pupil size, blurred vision, increased intraocular pressure, enlarged or obstructed prostate, difficulty urinating, narrowing or obstruction of the small intestine, enlarged colon, chronic constipation, enlarged lower esophagus, decreased gastric motility, constipation, dry mouth, throat irritation, impaired sweating, cardiovascular disease, arrhythmia, tachycardia, Parkinson's Disease, Alzheimer's Disease, dementia or myasthenia gravis).
Patent NZ-581129-A (NZ)
Title: Bladed coal diffuser with coal line balancing device
Inventor: LARUE ALBERT D
IPC: F23K3/02
Filed: 2009-11-12
Abstract: Disclosed is a coal nozzle assembly for a pulverized coal burner. The coal nozzle assembly includes a coal nozzle with an upstream inlet and a downstream outlet. The coal nozzle has a longitudinal direction and a wall having an inner surface. The assembly also includes a diffuser positioned in the coal nozzle closer to the upstream inlet than the downstream outlet. The diffuser has a body with a tapered upstream portion and a plurality of blades extending outwardly from the body. The assembly also has a flow conditioner adapted to direct a coal rope into the tapered upstream portion of the diffuser. The diffuser blades are angled with respect to the longitudinal direction of the coal nozzle such that a coal and air flow passing through the diffuser is swirled.
Patent NZ-582192-A (NZ)
Title: Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates
Inventor: BONNERT ROGER VICTOR
IPC: A61P11/00
Filed: 2008-07-01
Abstract: Disclosed is a compound of formula (I): as a mixture of (2S)-2-({ 3'-chloro-4'-[(2,2-dimethylpyrrolidin-1-yl)carbonyl]-5-fluorobiphenyl-2-yl} oxy)propanoic acid and (2R)-2-({ 3'-chloro-4'-[(2,2-dimethylpyrrolidin-1-yl)carbonyl]-5-fluorobiphenyl-2-yl} oxy)propanoic acid, or solvates thereof or pharmaceutically acceptable salts thereof or solvates of pharmaceutically acceptable salts. Also disclosed is a process for preparing a compound of formula (I) a pharmaceutical product comprising a compound of formula (I) and the use of a compound of formula (I) for the manufacture of a medicament for treating a disease mediated by prostaglandin D2.
Patent NZ-583623-A (NZ)
Title: Lipid encapsulated interfering RNA
Inventor: MACLACHLAN IAN
IPC: A61K47/48
Filed: 2004-07-16
Abstract: Provided is a nucleic acid-lipid particle, said nucleic acid-lipid particle comprising: an interfering RNA that silences the expression of a gene associated with a metabolic disease or disorder; a cationic lipid; a non-cationic lipid; and a conjugated lipid that inhibits aggregation of particles, wherein the conjugated lipid that inhibits aggregation of particles is a member selected from the group consisting of a polyethylene glycol (PEG)-lipid conjugate, a polyamide (ATTA)- lipid conjugate, and combinations thereof
Patent NZ-584383-A (NZ)
Title: Method for gas production from gas hydrate reservoirs
Inventor: GULLAPALLI IRENE
IPC: E21B36/00
Filed: 2008-09-04
Abstract: Disclosed is a two stage depressurization method for producing fluid from Class 3 hydrate reservoirs, comprising the steps of: (a) producing fluid from a hydrate interval within a Class 3 hydrate reservoir through a well at a constant pressure until a sufficient amount of secondary hydrates have formed within the hydrate interval; and (b) producing fluid from the hydrate interval through the well at a constant mass rate subsequent to the forming of the sufficient amount of secondary hydrates within the hydrate interval.
Patent NZ-586346-A (NZ)
Title: Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
Inventor: BENCSIK JOSEF R
IPC: A61K31/517
Filed: 2009-01-09
Abstract: Disclosed is a 1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-l-yl)propan-1-one of Formula I and salts thereof, wherein: R1 is alkyl having one OH substitution; R2 is hydrogen or F; and R3 is Cl or CF3. Also disclosed is the use of said compound in the treatment of inflammatory, hyperproliferative, cardiovascular, neurodegenerative, gynecological or dermatological disease or disorder.
Patent NZ-592910-A (NZ)
Title: Method of increasing filler content in papermaking
Inventor: CHENG WEIGUO
IPC: D21H21/18
Filed: 2009-11-25
Abstract: Disclosed herein is a method of papermaking, comprising the steps of: providing a blend of filler particles, at least one strength additive, and cellulose fiber stock, pre-treating the filler particles with a composition of matter (preferably acrylamide/diallyldimethylammonium chloride copolymer), combining the filler particles with the cellulose fiber stock after the filler particles have been pre-treated, treating the combination with at least one strength additive, and forming a paper mat from the combination, wherein at least 10% of the filler particles are precipitated calcium carbonate and at least 10% of the filler particles are ground calcium carbonate, and the cellulose fiber stock comprises a plurality of cellulose fibers and water.
Patent NZ-596334-A (NZ)
Title: Use of buoyant gases for the simulation of real fire sources
Inventor: ROBY RICHARD J
IPC: A62C37/00
Filed: 2010-05-11
Abstract: 596334 Disclosed is a method and apparatus to simulate a flow of products from a real fire without reproducing a thermal environment associated with the real fire. The method includes the release of a buoyant gas or a mixture of gases with a velocity profile to simulate smoke movement from real fire sources. The buoyant inert gas may be helium. In some embodiments, the buoyant gas is combined with artificial smoke, such as a tracer gas or an inert dye (e.g., a particulate) to provide a visual representation of the location and flow characteristics of the surrogate smoke that is released from a release apparatus. The release apparatus (140) includes a control system that follows a prescribed time-dependent flow rate to simulate different fire source configurations and growth rates. The buoyant gas serves as a surrogate for a flow of the products of combustion from real fire sources.
Patent NZ-602055-A (NZ)
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Inventor: HEXAMER LAURA
IPC: A61K31/18
Filed: 2011-03-10
Abstract: Disclosed herein are sulfonyl benzamide compounds, and the use thereof in the treatment of bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukmia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T -cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, chronic lymphocytic leukemia, myeloma, prostate cancer, small cell lung cancer or spleen cancer. In one embodiment the compound is N-({ 4-[(cyclohexylmethyl)amino]-3-nitrophenyl} sulfonyl)-3’-{ [(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]amino} biphenyl-4-carboxamide.
Patent NZ-605486-A (NZ)
Title: Spiro-cyclic amine derivatives as s1p modulators
Inventor: IWEMA BAKKER WOUTER I
IPC: A61K31/407
Filed: 2011-07-08
Abstract: ABSTRACT - 605486 The disclosure relates to spiro-benzofuran-piperidine derivatives of the formula (I) wherein R1; R2; R3; Q; -W-T-; R5; Z; and A have the definitions provided in the specification; or a pharmaceutically acceptable salt, a solvate or hydrate thereof or one or more N-oxides thereof. These compounds have affinity to sphingosine-1-phosphate (S1P) receptors and may be used in the treatment, alleviation or prevention of diseases and conditions in which an S1P receptor is involved, wherein the disease is a CNS disorder, such as a neurodegenerative disorder, in particular selected from a cognitive disorder, Alzheimer’s disease, (vascular) dementia, Nieman’s Pick disease, and cognitive deficits in schizophrenia, obsessive-compulsive behaviour, major depression, autism, multiple sclerosis and pain, and specifically a cognitive disorder, such as age-related cognitive decline.
Patent NZ-613313-A (NZ)
Title: Pharmaceutical formulation for topical administration comprising b220
Inventor: HOMMAN MOHAMMED
IPC: A61P31/22
Filed: 2012-02-17
Abstract: Disclosed herein is the use of 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline (B-220) or a pharmaceutically acceptable salt for the manufacturing of a medicament for use in the treatment of herpes virus infections of the skin or mucous membranes in a mammalian subject by topical administration of a therapeutically effective dose of said medicament to the skin or mucous membrane of the mammalian subject.
Patent NZ-615842-A (NZ)
Title: Facile synthesis of graphene, graphene derivatives and abrasive nanoparticles and their various uses, including as tribologically-beneficial lubricant additives
Inventor: SHANKMAN RICHARD S
IPC: F16N15/02
Filed: 2012-03-15
Abstract: Disclosed is a lubricating composition for a mechanical system (such as an internal combustion engine), comprising: a) a base lubricant; and b) one or more carbon-containing additives. The carbon-containing additive may be a sugar, sucrose, graphite, a pyranose, a furanose, a cyclic carbomer, a benzenoid, a sugar, a sugar alcohol, a sugar substitute, a sugar derivative, a cyclomethicone, a steroid, a cinnamate, a phenylphopanoid, a benzoate, a carboxylate, a benzopyran, a naturally-occurring or synthetic flavone or isoflavone, a salicylate, an antioxidant, a cyclic antioxidant, 4-vinylphenol, anthocyanidin, or chromenylium, a cyclic amino acid, a cyclohexane derivative, a benzene derivative, 1,2-dihydroxybenzene (catechol), 1,3-dihydroxybenzene (resorcinol), 1,4-dihydroxybenzene (hydroquinone), a naphthoate, an acrylate, a phthalate, a succinate, a carpate, a fluorophore, a pharmaceutical, a phosphate, a commercial edible personal/sexual lubricating composition including a sugar or sugar-substitute amphiphile, a commercial ultraviolet ray sunscreen formulation, a commercial skin cream formulation, a commercial hand sanitizer formulation, a commercial human or animal hair care product, a commercial hair dye formulation, a commercial pesticide, a compound that degrades to one or more of the above-mentioned additives during refluxing of the reaction mixture, or combinations thereof. When applied to the mechanical system, it is intended that the carbon-containing additive should be such that it is suitable for forming a tribologically-effective amount of at least one graphitic carbon-containing structure when the lubricating composition is exposed to heat sufficient to create locally pyrolitic conditions. At least some of the resultant graphitic carbon-containing structures comprise one or more surface-graphitized abrasive nanoparticles which having at least one non-carbon hetero-atom enveloped by an outer shell comprising substantially carbon, wherein the graphitic carbon-containing structure comprises a nano-polishing agent which may be able to remove asperities from an internal friction surface of the mechanical system.
Patent NZ-620181-A (NZ)
Title: Amphibious vehicle
Inventor: DANIEL GUIREC
IPC: B63C13/00
Filed: 2012-06-29
Abstract: An amphibious vehicle (100) is disclosed. The amphibious vehicle comprises a chassis (102) having a housing (106a) having an opening (202) with edges. A handling device (108a) having a fixed part (210) is fixed to the chassis. A movable part, having a wheel (104a), is mounted so as to be able to move on the fixed part. The movable part is able to move between a running position wherein the wheel is outside the housing, and a retracted position wherein the wheel is in the housing. A hatch system (204) having a hatch (206) may adopt alternately an open position in which it does not close off the opening or a closed position in which it comes into abutment against the edges of the opening and closes it off at least partly. The movable part may be moved into a locking position in which a locking element, such as the wheel, of the movable part locks the hatch in the closed position by abutment thereof against the hatch.
Patent NZ-625074-A (NZ)
Title: Synergistic fungicidal mixtures for fungal control in cereals
Inventor: YAO CHENGLIN
IPC: A61K31/41
Filed: 2010-10-06
Abstract: A fungicidal composition containing a fungicidally effective amount of a compound of Formula I, IV, or V and at least one fungicide selected from the group consisting of: azoxystrobin(methyl (aE)-2-[[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy]-a-(methoxymethylene)benzeneacetate), pyraclostrobin([2-[[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]phenyl]methoxycarbamate), penthiopyrad(N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide), isopyrazam(3-(difluoromethyl)-1-methyl-N-[1,2,3,4-tetrahydro-9-(1-methylethyl)-1,4-methanonaphthalen-5-yl]-1H-pyrazole-4-carboxamide), bixafen(N-(3’,4’-dichloro-5-fluoro[1,1’-biphenyl]-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide), boscalid(2-chloro-N-(4’-chlorobiphenyl-2-yl)nicotinamide), and chlorothalonil(tetrachlorisophthalonitrile). The fungi which is controlled may include: wheat brown rust (Puccinia recondita); stripe rust of wheat (Puccinia striiformis); leaf blotch of wheat (Mycosphaerella graminicola; Septoria tritici); glume blotch of wheat (Leptosphaeria nodorum; Stagonospora nodorum); spot blotch of barley (Cochliobolus sativum; Helminthosporium sativum); leaf spot of sugar beets (Cercospora beticola); leaf spot of peanut (Mycosphaerella arachidis; Cercospora arachidicola); cucumber anthracnose (Glomerella lagenarium; Colletotrichum lagenarium) and black sigatoka disease of banana (Mycosphaerellafijiensis).
Patent NZ-627594-A (NZ)
Title: Process for preparing animal feed
Inventor: HEAP FRANK CEDRIC
IPC: A23K10/33
Filed: 2012-11-19
Abstract: A method for the manufacture of animal feed supplement, typically a low moisture block (a vitreous/glassy block of carbohydrate comprising additives therein). The method comprises processing a carbohydrate-containing liquid composition to induce cracking and evaporation and thereby form a concentrated liquid composition; and solidifying the concentrated liquid composition to form the animal feed supplement. The carbohydrate-containing liquid composition is processed by continuously feeding the carbohydrate-containing liquid composition into a first (input) end of a thin film processor, subjecting the carbohydrate-containing liquid composition to cracking and evaporation within the thin film processor and continuously removing the concentrated liquid composition from the second (output) end of the thin film processor.
Patent NZ-629793-A (NZ)
Title: Exercise apparatus
Inventor: NUKU DAVE ARAMA
IPC: A63B23/00
Filed: 2013-11-21
Abstract: A suspension training system (1) includes a pulley (3), pulley housing, cable (7) and a securing mechanism. The disclosure notes that existing pulley based systems require more upper body strength and skill to operate and are restricted to use in certain types of exercises. The suspension training system (1) comprises the pulley housing which is rotatably supports the pulley (3). The cable (7), generally in the form of webbing, is operatively connected to the pulley (3) such that movement of the cable (7) rotates the pulley (3) relative to the pulley housing. The securing mechanism includes a first pin that can be engaged with a locking aperture of the pulley to secure the position of the pulley relative to the housing and a second pin that can be engaged with a locking aperture such as a loop or eyelet of the cable to secure the position of the cable relative to the housing.
Patent NZ-704814-A (NZ)
Title: 5-ht3 receptor antagonists
Inventor: HITCHCOCK STEPHEN
IPC: C07D498/08
Filed: 2013-07-16
Abstract: The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.